The HIV-1 Tat protein selectively enhances CXCR4 and inhibits CCR5 expression in megakaryocytic K562 cells

The hematopoietic compartments act as long-term reservoirs for human immunodeficiency virus type-1 (HIV-1). Although hematopoietic progenitor cells (HPCs) are rarely infectable, HPCs committed to the megakaryocytic lineage can be infected and support a productive infection by both the X4 and R5 strains of HIV-1. Indeed, in contrast to the CD34+ progenitors, the lineage-committed HPCs express high levels of the HIV-1 co-receptors, CXCR4 and CCR5. The HIV-1 transactivator (Tat) protein has been shown to alter co-receptor expression in T lymphocytes and macrophages. We hypothesized that Tat may regulate co-receptor expression in lineage-specific HPCs as well. We have monitored the effects of Tat protein on co-receptor expression and on lineage-specific differentiation, using the HPC cell line, K562. Butyric acid (BA)-induced erythroid differentiation in K562 cells was suppressed by 1-100 ng/ml of Tat, as evident from a 70-80% decrease in hemoglobin (Hb) production and a 10-30-fold decrease in glycophorin-A expression. However, Tat treatment enhanced phorbol myristate acetate (PMA)-induced megakaryocytic differentiation, as evident from a 180-210% increase in 3H-serotonin uptake and a 5-12-fold increase in CD61 expression. Tat did not significantly alter co-receptor expression in erythroid cells. However, Tat co-treatment profoundly effected both CXCR4 and CCR5 gene expression and protein levels in megakaryocytic cells. In PMA-stimulated cells, Tat increased CXCR4 and decreased in CCR5 expression, this was potentiated in cells chronically exposed to Tat. In conclusion, Tat protein suppresses erythroid and facilitates megakaryocytic differentiation of K562 cells. In megakaryocytic cells, Tat differentially effected CXCR4 and CCR5 expression. Because megakaryocytes may play a crucial role in HIV-1 infectivity in viral reservoirs, our findings implicate a role for Tat protein in dictating co-receptor usage in lineage-committed HPCs.     

膜去极化与cAMP在胰岛细胞株HIT中诱导CBP片段的转录活性

为了研究 Ｃ Ｂ Ｐ在胰岛 Ｈ Ｉ Ｔ 细胞中调节基因转录的机制,将不同的 Ｃ Ｂ Ｐ片段瞬时转染到细胞中,观察其转录活性．实验表明,在胰岛 Ｈ Ｉ Ｔ 细胞中,膜去极化及 ｃ Ａ Ｍ Ｐ 均可诱导 Ｃ Ｂ Ｐ３０（ Ｃ Ｒ Ｅ Ｂ结合功能区）转录活性增强,并有协同效应． Ｐ Ｋ Ｃ对 Ｃ Ｂ Ｐ３０ 的转录活性无影响;与 Ｃ Ｒ Ｅ Ｂ有更强结合力的 Ｃ Ｂ Ｐ Ｋ Ｉ Ｘ Ｓ／ Ｂ（氨基酸序列短于 Ｃ Ｂ Ｐ３０ 的 Ｃ Ｒ Ｅ Ｂ结合功能区）其基本转录活性及膜去极化、ｃ Ａ Ｍ Ｐ诱导下的转录活性均比 Ｃ Ｂ Ｐ３０ 更强．反义 Ｃ Ｒ Ｅ Ｂ 的过度表达可降低 ｃ Ａ Ｍ Ｐ诱导的 Ｃ Ｂ Ｐ的转录活性．提示在胰岛 Ｈ Ｉ Ｔ 细胞中,膜去极化及 ｃ Ａ Ｍ Ｐ对共转录因子 Ｃ Ｂ Ｐ转录活性的调节作用通过 Ｃ Ｒ Ｅ Ｂ介导．     

Lactosylceramide alpha2,3-sialyltransferase is induced via a PKC/ERK/CREB-dependent pathway in K562 human leukemia cells

Previously we showed that the human GM3 synthase gene was expressed during the induction of megakaryocytic differentiation in human leukemia K562 cells by phorbol 12-myristate 13-acetate (PMA). In this study we found that treatment of PMA-induced K562 cells with G?6976, a specific inhibitor of PKC, and U0126, an inhibitor of the extracellular signal-regulated kinase (ERK) reduced expression of GM3 synthase, whereas wortmannin, an inhibitor of phosphoinositide 3-kinase (PI3K) did not. Moreover, activation of ERK and cAMP response element binding protein (CREB) was prevented by pretreatment with G?6976 and U0126. PMA stimulated the promoter activity of the 5'-flanking region from -177 to -83 region of the GM3 synthase gene, and mutation or deletion of a CREB site located around -143 of the promoter reduced PMA-stimulated promoter activity, as did the inhibitors G?6976 and U0126. Our results demonstrate that induction of GM3 synthase during megakaryocytic differentiation in PMA-stimulated human leukemia K562 cells depends upon the PKC/ERK/CREB pathway.